{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:27:33Z","timestamp":1788852453797,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clinthera.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:18:00Z","timestamp":1771535880000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unseen but Impactful: Gout as a Neglected Comorbidity in Cardiovascular Care"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9131-009X","authenticated-orcid":false,"given":"Zaayneb","family":"Sediqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-270X","authenticated-orcid":false,"given":"Oliver Buchhave","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8314-0608","authenticated-orcid":false,"given":"S\u00f8ren","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-3882","authenticated-orcid":false,"given":"Steen Hylgaard","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-8447","authenticated-orcid":false,"given":"Claus","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.01.006_bib0001","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0002","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0003","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","article-title":"Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout","volume":"73","author":"Perez-Ruiz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0006","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/cells13171471","article-title":"A comprehensive review of cardiovascular disease management: cardiac biomarkers, imaging modalities, pharmacotherapy, surgical interventions, and herbal remedies","volume":"13","author":"Netala","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001015","article-title":"Failure to reach uric acid target of <0.36 mmol\/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality","volume":"5","author":"P\u00e9rez Ruiz","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0009","doi-asserted-by":"crossref","unstructured":"Rasmussen C., Walther Larsen J., C.W. Holm P, L. Nielsen G. Gout: an overlooked disease in patients with diabetes? A Danish prospective cohort study with 2 years of follow-up. 2025. Available from: https:\/\/diabetesjournals.figshare.com\/articles\/figure\/_b_Gout_An_Overlooked_Disease_in_Patients_With_Diabetes_A_Danish_Prospective_Cohort_Study_With_2_Years_of_Follow-Up_b_\/28020806.","DOI":"10.2337\/figshare.28020806"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/gucdd1030014","article-title":"Gout and Cardiovascular Disease: mechanisms, Risk Estimations, and the Impact of Therapies","volume":"1","author":"Andr\u00e9s","year":"2023","journal-title":"GUCDD"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0011","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11606-017-4233-5","article-title":"Effects of discontinuation of urate-lowering therapy: a systematic review","volume":"33","author":"Beslon","year":"2018","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004179","article-title":"Optimising gout treatment: insights from a nurse-led cohort study","volume":"10","author":"Rasmussen","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0013","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/clc.23266","article-title":"The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis","volume":"42","author":"Liang","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-092522","article-title":"Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in Sweden","volume":"15","author":"Drivelegka","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(22)01657-9","article-title":"Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Mackenzie","year":"2022","journal-title":"The Lancet"},{"issue":"22","key":"10.1016\/j.clinthera.2026.01.006_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212394","article-title":"Uric acid in inflammation and the pathogenesis of atherosclerosis","volume":"22","author":"Kimura","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.clinthera.2026.01.006_bib0017","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/biomedicines10123067","article-title":"Hyperuricemia and endothelial function: is it a simple association or do gender differences play a role in this binomial?","volume":"10","author":"Ciarambino","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0018","article-title":"The potential relationship of coronary artery disease and hyperuricemia: a cardiometabolic risk factor","volume":"9","author":"Li","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0019","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/s12872-024-04055-y","article-title":"Serum uric acid: an independent risk factor for cardiovascular disease in Pakistani Punjabi patients","volume":"24","author":"Hussain","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102195","article-title":"Xanthine oxidoreductase: a leading actor in cardiovascular disease drama","volume":"48","author":"Polito","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0021","first-page":"e123","article-title":"Uric acid and risk of cardiovascular disease and mortality: a longitudinal cohort study","volume":"38","author":"Kim","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0022","unstructured":"ATCDDD \u2013 ATC\/DDD index [cited 2025 Sep 3]. Available from: https:\/\/atcddd.fhi.no\/atc_ddd_index\/?code=M04AA01"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0023","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0024","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.30119","article-title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","volume":"63","author":"Stamp","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2026.01.006_bib0025","series-title":"Dansk Reumatologisk Selskab \u2013 Nationale behandlingsvejledninger (NBV)","author":"Christiansen","year":"2025"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:07:50Z","timestamp":1774620470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826000093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0149291826000093"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.01.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unseen but Impactful: Gout as a Neglected Comorbidity in Cardiovascular Care","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}